1. Bluher M. Obesity: global epidemiology and pathogenesis. Nat. rev. Endocrinol. 2019; 15(5): 288-98. [
DOI:10.1038/s41574-019-0176-8]
2. Hasani-Ranjbar S, Jouyandeh Z and Abdollahi M. A systematic review of anti-obesity medicinal plants - an update. J. diabetes metab. disord. 2013; 12(1): 28. [
DOI:10.1186/2251-6581-12-28]
3. Singh M, Kadhim MM, Turki Jalil A, Oudah SK, Aminov Z, Alsaikhan F, Jawhar ZH, Ramírez-Coronel AA and Farhood B. A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity. Cancer. Cell. Int. 2023; 23(1): 88. [
DOI:10.1186/s12935-023-02936-4]
4. Haddad Y, Vallerand D, Brault A and Haddad PS. Antioxidant and hepatoprotective effects of silibinin in a rat model of nonalcoholic steatohepatitis. Evid. Based. Complement. Alternat. Med. 2011; 2011: nep164. [
DOI:10.1093/ecam/nep164]
5. Ramakrishnan G, Jagan S, Kamaraj S, Anandakumar P and Devaki T. Silymarin attenuated mast cell recruitment thereby decreased the expressions of matrix metalloproteinases-2 and 9 in rat liver carcinogenesis. Investigational new drugs 2009; 27(3): 233-40. [
DOI:10.1007/s10637-008-9163-y]
6. Skottova N, Vecera R, Urbanek K, Vana P, Walterova D and Cvak L. Effects of polyphenolic fraction of silymarin on lipoprotein profile in rats fed cholesterol-rich diets. Pharmacol. res. 2003; 47(1): 17-26. [
DOI:10.1016/S1043-6618(02)00252-9]
7. Sayin FK, Buyukbas S, Basarali MK, Alp H, Toy H and Ugurcu V. Effects of Silybum marianum Extract on High-Fat Diet Induced Metabolic Disorders in Rats. Polish. J. Food. Nutr. Sci. 2016; 66(1): 43-9. [
DOI:10.1515/pjfns-2015-0014]
8. Jones TE, Basilio JL, Brophy PM, McCammon MR and Hickner RC. Long-term exercise training in overweight adolescents improves plasma peptide YY and resistin. Obes. (Silver Spring, Md) 2009; 17(6): 1189-95. [
DOI:10.1038/oby.2009.11]
9. Ghitza UE, Nair SG, Golden SA, Gray SM, Uejima JL, Bossert JM and Shaham Y. Peptide YY3-36 decreases reinstatement of high-fat food seeking during dieting in a rat relapse model. J. Neurosci. 2007; 27(43): 11522-32. [
DOI:10.1523/JNEUROSCI.5405-06.2007]
10. Abdul Kadir NAA, Rahmat A and Jaafar HZ. Protective effects of tamarillo (Cyphomandra betacea) extract against high fat diet induced obesity in Sprague-Dawley rats. J. Obes. 2015; 2015. [
DOI:10.1155/2015/846041]
11. Silva Gonçalves GM, Barros PP, da Silva GH, Ferreira Watanabe J and de Camargo Eisinger AB. Influence of silymarin and chromium picolinate on the pharmacotherapy of rats with induced diabetes. Rev. Colomb. Cienc. Quim. Farm. 2020; 49(1): 5-16. [
DOI:10.15446/rcciquifa.v49n1.81648]
12. Babaei P, Shirkouhi SG, Hosseini R and Soltani Tehrani B. Vitamin D is associated with metabotropic but not neurotrophic effects of exercise in ovariectomized rats. Diabetol. Metab. Syndr. 2017; 9(1):1-9. [
DOI:10.1186/s13098-017-0288-z]
13. Latour MG, Shinoda M and Lavoie J-M. Metabolic effects of physical training in ovariectomized and hyperestrogenic rats. J. Appl. Physiol. 2001; 90(1): 235-41. [
DOI:10.1152/jappl.2001.90.1.235]
14. Mehdipoor M, Damirchi A, Tousi SMTR and Babaei P. Concurrent vitamin D supplementation and exercise training improve cardiac fibrosis via TGF-β/Smad signaling in myocardial infarction model of rats. J. Physiol. Biochem. 2021; 77(1): 75-84. [
DOI:10.1007/s13105-020-00778-6]
15. Seo DY, Kwak HB, Lee SR, Cho YS, Song I-S, Kim N, Bang HS, Rhee BD, Ko KS and Park BJ. Effects of aged garlic extract and endurance exercise on skeletal muscle FNDC-5 and circulating irisin in high-fat-diet rat models. Nutr. Res. Pract. 2014; 8(2): 177-82. [
DOI:10.4162/nrp.2014.8.1.177]
16. Shao Y, Yuan G, Zhang J and Guo X. Liraglutide reduces lipogenetic signals in visceral adipose of db/db mice with AMPK activation and Akt suppression. Drug. Des. Devel. Ther. 2015; 9: 1177. [
DOI:10.2147/DDDT.S79175]
17. Nianhong Y, Chongjian W, Mingjia X, Limei M, Liegang L and Xiufa S. Interaction of dietary composition and PYY gene expression in diet-induced obesity in rats. J. Huazhong. Univ. Sci. Technol. Med. Sci. 2005; 25(3): 243-6. [
DOI:10.1007/BF02828131]
18. You JS, Lee YJ, Kim KS, Kim SH and Chang KJ. Ethanol extract of lotus (Nelumbo nucifera) root exhibits an anti-adipogenic effect in human pre-adipocytes and anti-obesity and anti-oxidant effects in rats fed a high-fat diet. Nutr. Res. 2014; 34(3):258-67. [
DOI:10.1016/j.nutres.2014.01.003]
19. Hamza N, Berke B, Cheze C, Agli AN, Robinson P, Gin H and Moore N. Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J. Ethnopharmacol. 2010; 128(2): 513-8. [
DOI:10.1016/j.jep.2010.01.004]
20. Feng B, Meng R, Huang B, Shen S, Bi Y and Zhu D. Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice. Free Radic. Res. 2016; 50(3): 314-27. [
DOI:10.3109/10715762.2015.1116689]
21. Gu M, Zhao P, Huang J, Zhao Y, Wang Y, Li Y, Li Y, Fan S, Ma YM, Tong Q, Yang L, Ji G and Huang Ch. Silymarin ameliorates metabolic dysfunction associated with diet-induced obesity via activation of Farnesyl X receptor. Front. Pharmacol. 2016; 7: 345. [
DOI:10.3389/fphar.2016.00345]
22. Guo Y, Wang S, Wang Y and Zhu T. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Pharm. Biol. 2016; 54(12): 2995-3000. [
DOI:10.1080/13880209.2016.1199042]
23. Prakash P, Singh V, Jain M, Rana M, Khanna V, Barthwal MK and Dikshit M. Silymarin ameliorates fructose induced insulin resistance syndrome by reducing de novo hepatic lipogenesis in the rat. Eur. J. Pharmacol. 2014; 727: 15-28. [
DOI:10.1016/j.ejphar.2014.01.038]
24. Falasca K, Ucciferri C, Mancino P, Vitacolonna E, De Tullio D, Pizzigallo E, Conti P and Vecchiet J. Treatment with silybin-vitamin E-phospholipid complex in patients with hepatitis C infection. J. Med. Virol. 2008; 80(11): 1900-6. [
DOI:10.1002/jmv.21292]
25. Vengerovskii AI, Khazanov VA, Eskina KA and Vasilyev KY. Effects of Silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull. Exp. Biol. Med. 2007; 144(1): 53-6. [
DOI:10.1007/s10517-007-0252-2]
26. Tomeleri CM, Souza MF, Burini RC, Cavaglieri CR, Ribeiro AS, Antunes M, Nunes JP, Venturini D, Barbosa DS, Sardinha LB and Cyrino ES. Resistance training reduces metabolic syndrome and inflammatory markers in older women: A randomized controlled trial. J. Diabetes 2018; 10(4): 328-37. [
DOI:10.1111/1753-0407.12614]
27. Stensvold D, Tjønna AE, Skaug E-A, Aspenes S, Stølen T, Wisløff U and Slørdahl SA. Strength training versus aerobic interval training to modify risk factors of metabolic syndrome. J. Appl. Physiol. 2010; 108(4): 804-10. [
DOI:10.1152/japplphysiol.00996.2009]
28. Soto C, Recoba R, Barrón H, Alvarez C and Favari L. Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comparative Biochemistry and Physiology Part C: Toxicol. & Pharmacol. 2003; 136(3): 205-12. [
DOI:10.1016/S1532-0456(03)00214-X]
29. Yao J, Zhi M, Gao X, Hu P, Li C and Yang X. Effect and the probable mechanisms of silibinin in regulating insulin resistance in the liver of rats with non-alcoholic fatty liver. Braz. J. Med. Biol. Res. 2013; 46: 270-7. [
DOI:10.1590/1414-431X20122551]
30. Xiao F, Gao F, Zhou S and Wang L. The therapeutic effects of Silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis. Medicine 2020; 99(40): e22249. [
DOI:10.1097/MD.0000000000022249]
31. Vecera R, ZachaYová A, Orolin J, Skottova N and Anzenbacher P. The effect of Silymarin on expression of selected ABC transporters in the rat. Vet. Med. 2018; 56: 59-62. [
DOI:10.17221/1579-VETMED]
32. Sobolova L, Skottova N, Vecera R and Urbanek K. Effect of Silymarin and its polyphenolic fraction on cholesterol absorption in rats. Pharmacol. Res. 2006; 53(2): 104-12. [
DOI:10.1016/j.phrs.2005.09.004]
33. Famouri F, Salehi M-M, Rostampour N, Hashemi E and Shahsanaee A. The effect of Silymarin on non-alcoholic fatty liver disease of children. J. Herbmed. Pharmacol. 2017; 6(1): 16-20.
34. Bulló M, García Lorda P, Megias I and Salas Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. Res. 2003; 11(4): 525-31. [
DOI:10.1038/oby.2003.74]
35. Sheth SG, Gordon FD and Chopra S. Nonalcoholic steatohepatitis. Ann. Intern. Med. 1997; 126(2): 137-45. [
DOI:10.7326/0003-4819-126-2-199701150-00008]
36. Martins C, Kulseng B, King NA, Holst JJ and Blundell JE. The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J. Clin. Endocrinol. Metab. 2010; 95(4): 1609-16. [
DOI:10.1210/jc.2009-2082]
37. Stensel D. Exercise, Appetite and appetite-regulating hormones: Implications for food intake and weight control. Ann. Nutr. Metab. 2010; 57(Suppl. 2): 36-42. [
DOI:10.1159/000322702]
38. van den Hoek AM, Heijboer AC, Corssmit EP, Voshol PJ, Romijn JA, Havekes LM and Pijl H. PYY3-36 reinforces insulin action on glucose disposal in mice fed a high-fat diet. Diabetes 2004; 53(8): 1949-52. [
DOI:10.2337/diabetes.53.8.1949]
39. van den Hoek AM, Heijboer AC, Voshol PJ, Havekes LM, Romijn JA, Corssmit EP and Pijl H. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice. Am. J. Physiol. Endocrinol. Metab. 2007; 292(1): E238-45. [
DOI:10.1152/ajpendo.00239.2006]
40. Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM and Kendall ES. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. J. Nutr. 2006; 136(1): 195-201. [
DOI:10.1093/jn/136.1.195]
41. Doucet E, Laviolette M, Imbeault P, Strychar I, Rabasa-Lhoret R and Prud'homme D. Total peptide YY is a correlate of postprandial energy expenditure but not of appetite or energy intake in healthy women. Metabolism. 2008; 57(10): 1458-64. [
DOI:10.1016/j.metabol.2008.05.017]
42. Wu W-q, Peng S, Wan X-q, Lin S, Li L-y and Song Z-y. Physical exercise inhibits atherosclerosis development by regulating the expression of neuropeptide Y in apolipoprotein E-deficient mice. Life. Sci. 2019; 237: 116896. [
DOI:10.1016/j.lfs.2019.116896]
43. Khajehnasiri N, Khazali H, Sheikhzadeh F and Ghowsi M. One-month of high-intensity exercise did not change the food intake and the hypothalamic arcuate nucleus proopiomelanocortin and neuropeptide Y expression levels in male Wistar rats. Endocr. Regul. 2019; 53:8-13. [
DOI:10.2478/enr-2019-0002]
44. Touati S, Meziri F, Devaux S, Berthelot A, Touyz RM and Laurant P. Exercise reverses metabolic syndrome in high-fat diet-induced obese rats. Med. Sci. Sports. Exerc. 2011; 43(3): 398-407. [
DOI:10.1249/MSS.0b013e3181eeb12d]
45. Maestu J, Juerimaee J, Valter I and Juerimaee T. Increases in ghrelin and decreases in leptin without altering adiponectin during extreme weight loss in male competitive bodybuilders. Metabolism. 2008; 57(2): 221-5. [
DOI:10.1016/j.metabol.2007.09.004]
46. Hagobian TA, Sharoff CG and Braun B. Effects of short-term exercise and energy surplus on hormones related to regulation of energy balance. Metab. Clin. Exp. 2008; 57(3): 393-8. [
DOI:10.1016/j.metabol.2007.10.016]
47. Karamouzis I, Karamouzis M, Vrabas IS, Christoulas K, Kyriazis N, Giannoulis E and Mandroukas K. The effects of marathon swimming on serum leptin and plasma neuropeptide Y levels. Clin. Chem. Lab. Med. 2002. [
DOI:10.1515/CCLM.2002.023]